35 results
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
27 Mar 24
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
7:30am
transition, which resulted in the inclusion of medical affairs expenses and certain indirect supply chain and quality assurance expenses in SG&A reporting
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
14 Nov 23
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
12:00am
supply chain and quality assurance expenses in SG&A reporting, contributed $4.4 million to the increase in the quarter. Additionally, excess capacity
DEF 14A
fsmkh
22 Jun 22
Definitive proxy
4:22pm
PRE 14A
dst6sdfro23kuf
10 Jun 22
Preliminary proxy
4:25pm
10-Q
rr1kkrg9s03c
12 May 22
Quarterly report
7:42am
10-K
m7kqpg tvskhws64shu
24 Mar 22
Annual report
7:30am
6-K
EX-99.1
ji5wxw 8q4q
13 Aug 21
Report of Foreign Private Issuer
4:04pm
6-K
EX-99.1
pg1lm
7 Jun 21
Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update
7:11am
6-K
EX-99.1
18spmj0l
9 Mar 21
Gamida Cell Reports Full Year 2020 Financial Results and Provides Company Update
4:08pm
6-K
EX-99.2
rt4wt de8
9 Dec 20
Report of Foreign Private Issuer
3:37pm